Omnicell, Inc.

BMV:OMCL * Stock Report

Market Cap: Mex$37.1b

Omnicell Past Earnings Performance

Past criteria checks 1/6

Omnicell's earnings have been declining at an average annual rate of -38.1%, while the Medical Equipment industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 1.2% per year. Omnicell's return on equity is 1.6%, and it has net margins of 1.7%.

Key information

-38.09%

Earnings growth rate

-39.43%

EPS growth rate

Medical Equipment Industry Growth12.91%
Revenue growth rate1.22%
Return on equity1.63%
Net Margin1.67%
Next Earnings Update30 Jul 2026

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Omnicell makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BMV:OMCL * Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 261,2252040989
31 Dec 251,185240988
30 Sep 251,1782040592
30 Jun 251,1502339889
31 Mar 251,1362139089
31 Dec 241,1121338090
30 Sep 241,064-1837388
30 Jun 241,080-2138391
31 Mar 241,103-2139693
31 Dec 231,147-2042693
30 Sep 231,186-3445497
30 Jun 231,235-2346397
31 Mar 231,268-18475101
31 Dec 221,2966466101
30 Sep 221,3094845396
30 Jun 221,2586143891
31 Mar 221,1997241283
31 Dec 211,1327838176
30 Sep 211,0708035469
30 Jun 219876032765
31 Mar 219143530665
31 Dec 208923229766
30 Sep 208913829870
30 Jun 209064929871
31 Mar 209246929870
31 Dec 198976129069
30 Sep 198605427467
30 Jun 198364826966
31 Mar 198073826664
31 Dec 187873825965
30 Sep 187725425864
30 Jun 187544824964
31 Mar 187474424567
31 Dec 177133124166
30 Sep 17688-123365
30 Jun 17678-623864
31 Mar 17670-924360
31 Dec 166961023058
30 Sep 16651823152
30 Jun 165991421046
31 Mar 165392418441
31 Dec 154853116535
30 Sep 154763216634

Quality Earnings: OMCL * has high quality earnings.

Growing Profit Margin: OMCL *'s current net profit margins (1.7%) are lower than last year (1.9%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: OMCL *'s earnings have declined by 38.1% per year over the past 5 years.

Accelerating Growth: OMCL *'s has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: OMCL * had negative earnings growth (-3.5%) over the past year, making it difficult to compare to the Medical Equipment industry average (3%).

Return on Equity

High ROE: OMCL *'s Return on Equity (1.6%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/16 02:12
End of Day Share Price 2026/05/05 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Omnicell, Inc. is covered by 19 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Raymond MyersBenchmark Company
William SutherlandBenchmark Company
Zhilin LongBerenberg